Content Services
- Technical Writing
- Training & eLearning
- Financial Reports
- Digital Marketing
- SEO & Content Optimization
Translation Services
- Video Localization
- Software Localization
- Website Localization
- Translation for Regulated Companies
- Interpretation
- Instant Interpreter
- Live Events
- Language Quality Services
Testing Services
- Functional QA & Testing
- Compatibility Testing
- Interoperability Testing
- Performance Testing
- Accessibility Testing
- UX/CX Testing
Solutions
- Translation Service Models
- Machine Translation
- Smart Onboarding™
- Aurora AI Studio™
Our Knowledge Hubs
- Positive Patient Outcomes
- Modern Clinical Trial Solutions
- Future of Localization
- Innovation to Immunity
- COVID-19 Resource Center
- Disruption Series
- Patient Engagement
- Lionbridge Insights
Life Sciences
- Pharmaceutical
- Clinical
- Regulatory
- Post-Approval
- Corporate
- Medical Devices
- Validation and Clinical
- Regulatory
- Post-Authorization
- Corporate
Banking & Finance
Retail
Luxury
E-Commerce
Games
Automotive
Consumer Packaged Goods
Technology
Industrial Manufacturing
Legal Services
Travel & Hospitality
SELECT LANGUAGE:
2023 has significantly changed how we approach life sciences translation, patient communications, and the industry in general. We’re cautiously considering how to benefit from generative AI while balancing risk and protecting patients. We’re learning best practices for clinical trial translation under the EU MDR and striving towards more inclusive research focused on patient outcomes.
Review our popular 2023 life sciences blogs below.
Lionbridge’s Life Sciences team reviews a year of European Union Clinical Trials Regulation (EU CTR) compliance. We share best practices and learnings from our experience providing life sciences translation services to customers impacted by this relatively new regulation.
Discover current and potential use cases for generative AI in the Life Sciences industry. Learn why slow adoption and risk management are crucial to protecting patient safety.
Finding the optimal clinical trial to participate in is a serious challenge for many patients. Further complicating matters, there is a misconception that certain minority groups don’t want to engage in clinical trials. However, they don’t participate because they’re often not offered opportunities. Read the article to learn tactics for recruiting from more diverse pools of patients.
Read about the essential steps to writing effective trial results for multi-regional clinical trials. Understand how to reach various audiences, including patients unfamiliar with technical medical terminology.
Translation and migration projects associated with electronic Clinical Outcome Assessment (eCOA) measures must meet rigorous clinical research standards and timelines. Understand how Lionbridge has assisted customers with handling clinical research’s linguistic and technological requirements.
In this blog about clinical trial management, Lionbridge experts consider the challenges inherent with multilingual and multi-regional clinical trials. Uncover more about language compliance requirements, improving patient outcomes, and cutting-edge clinical research language support.
In this blog about clinical trial management, Lionbridge experts consider the challenges inherent with multilingual and multi-regional clinical trials. Uncover more about language compliance requirements, improving patient outcomes, and cutting-edge clinical research language support.
Dive into the extension of the European Union Medical Devices Regulation transition period. Learn why the extension occurred, the complications it will cause, and the implications for medical device manufacturers.
Read our blog post about the European Medical Device Regulation (EU MDR) and its implications for device makers. This post will review the MDR’s increased language requirements. These new requirements will both burden device makers and present opportunities.
To meet the stringent, rigorous process of clinical labeling, it’s essential to work with reliable, accurate, and efficient life sciences translation services. Read our case study to see how Lionbridge has been helping a global biopharmaceutical company for nearly a decade. We assist in maintaining compliance and meeting tight deadlines while translating label phrases for Investigational Medicinal Product (IMP) labels.
Generative AI tools may feel futuristic and risky, but Lionbridge has been preparing and exploring how these tools can be applied to our life sciences translation services. Learn more from Paraic O’Donnell, a Life Sciences industry veteran, about how we apply Generative AI for our Life Sciences clients — and some future use cases.
Interested in learning more about life sciences and generative AI? Exploring potential generative AI use cases for your organization? We can assist with these areas or your life sciences translation needs. You can rely on our deep experience, knowledge, and innovative technology. Contact us today to find out more about Lionbridge’s life sciences translation solutions.